Clinical features and outcome of children with first marrow relapse of acute lymphoblastic leukemia expressing BCR-ABL fusion transcripts

Blood

Volumn 87, Issue 4, 1996, Pages 1532-1538

  Beyermann, Birgit ^a   Agthe, Alexander G ^a   Adams, Hans Peter ^a   Seeger, Karlheinz ^a   Linderkamp, Christin ^a   Goetze, Gisela ^a   Ludwig, Wolf Dieter ^a   Henze, Günter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CYTARABINE; ETOPOSIDE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CHILD; CHROMOSOME ANALYSIS; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFANT; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 0030020398     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.4.1532.bloodjournal8741532     Document Type: Article

References (39)

1. Bloomfield CD, Goldman AI, Alimena G, Berger R, Borgstršm GH, Brandt L, Catovsky D, DeLaChapelle A, Dewald GW, Garson OM, Garwicz S, Golomb HM, Hossfeld DK, Lawler SD, Mitelman F, Nilsson P, Pierre RV, Philip P, Prigogina E, Rowley JD, Sakurai M, Sandberg AA, Secker-Walker LM, Tricot G, Van den Berghe H, Van Orshoven A, Vuopio P, Whang-Peng J: Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood 67:415, 1986
2. Williams DL, Harber J, Murphy SB, Look AT, Kalwinsky DK, Rivera G, Melvin SL, Stass S, Dahl GV: Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia. Blood 68:205, 1986
3. Maurer J, Janssen JW, Thiel E, van Denderen J, Ludwig WD, Aydemir U, Heinze B, Fonatsch C, Harbott J, Reiter A, Riehm H, Hoelzer D, Bartram CR: Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 337:1055, 1991
4. van der Plas DC, Hählen K, Hagemeijer A: Prognostic significance of karyotype at diagnosis in childhood acute lymphoblastic anemia. Leukemia 6:176, 1992
5. Heerema NA, Palmer CO, Weetman R, Bertolone S: Cytogenetic analysis in relapsed childhood lymphoblastic leukemia Leukemia 6:185, 1992
6. Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132:1497, 1960
7. Secker-Walker LM, Craig JM: Prognostic implications of breakpoint and lineage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: A review. Leukemia 7:147, 1993
8. 1 translocation. Nature 315:758, 1985
9. De Klein A, Hagemeijer A, Bartram CR, Houwen R, Hoefsloot L, Carbonell F, Chan L, Barnett M, Greaves M, Kleihauer E, Heisterkamp N, Groffen J, Grosveld G: Bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia. Blood 68:1369, 1986
10. Fainstein E, Marcelle C, Rosner A, Canaani E, Gale RP, Dreazen O, Smith SD, Croce CM: A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature 330:386, 1987
11. Clark SS, McLaughlin J, Crist WM, Champlin R, Witte ON: Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. Science 235:85, 1987
12. Hermans A, Heisterkamp N, von Linden M, van Baal S, Meijer D, van der Plas D, Wiedemann LM, Groffen J, Bootsma D, Grosveld G: Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 51:33, 1987
13. Fletcher JA, Lynch EA, Kimball VM, Donnelly M, Tantravahi R, Sallan SE: Translocation (9; 22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood 77.435, 1991
14. Tuszynski A, Dhut S, Young BD, Lister TA, Rohatiner AZ, Amess JA, Chaplin T, Dorey E, Gibbons B: Detection and significance of bcr-abl mRNA transcripts and fusion proteins in Philadelphia-positive adult acute lymphoblastic leukemia. Leukemia 7(10):1504, 1993
15. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON, McCormick FP: Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 85:5698, 1988
16. Kurzrock R, Shtalrid M, Romero P, Kloetzer WS, Talpas M, Trujillo JM, Blick M, Beran M, Gutterman JU: A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature 325:631, 1987
17. Chan LC, Karhi KK, Rayter SI, Heisterkamp N, Eridani S, Powles R, Lawler SD, Groffen J, Foulkes JG, Greaves MF, Wiedemann LM. A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia. Nature 325:635, 1987
18. Secker-Walker LM, Craig JM, Hawkins JM, Hoffbrand AV: Philadelphia positive acute lymphoblastic leukemia in adults: age distribution. BCR breakpoint and prognostic significance. Leukemia 5:196, 1991
19. Russo C, Carroll A, Kohler S, Borowitz M, Amylon M, Homans A, Kedar A, Sinister J, Land V, Crist W, Pullen J, Link M: Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 77:1050, 1991
20. Westbrook CA, Hooberman AL, Spino C, Dodge RK, Larson RA, Davey F, Wurster-Hill DH, Sobol RE, Schiffer C, Bloomfield CD: Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). Blood 80.2983, 1992
21. Crist W, Carroll A, Shuster J, Jackson J, Head D, Borowitz M, Behm F, Link M, Steuber P, Ragab A, Hirt A, Brock B, Land V, Pullen J: Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood 76:489, 1990
22. Bührer C, Hartmann R, Fengler R, Dopfer R, Gadner H, Gerein V, Göbel U, Reiter A, Ritter J, Henze G: Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. Med Pediatr Oncol 21:470, 1993
23. Fengler R, Hartmann R, Bode U, Janka G, Jürgens H, Riehm H, Henze G: Risk of CNS relapse after systemic relapse of childhood acute lymphoblastic leukemia. Haematol Blood Transfus 33:511, 1990
24. Henze G, Fengler R, Hartmann R, Kornhuber B, Janka-Schaub G, Niethammer D, Riehm H: Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM Group. Blood 78:1166, 1991
25. Henze G, Fengler R, Hartmann R, Ritter J, Niethammer D, Schwabe D, Havers W, Treuner J, Gadner H, Haas R, Janka-Schaub G, Rieske K, Reiter A, Selle B, Dorffei W, Schmiegelow K, Feldges A, Riehm H. High dose versus intermediate dose MTX for relapsed childhood ALL: Interim results of the randomized multicentric trial ALL-REZ BFM 90. Med Pediatr Oncol 23:190, 1994 (abstr)
26. Wolfrom C, Hartmann R, Fengler R, Brühmuller S, Ingwersen A, Henze G: Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia. J Clin Oncol 11:827, 1993
27. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
28. 1-positive acute lymphocytic leukemia (ALL). Science 239:775, 1988
29. Mes-Masson AM, McLaughlin J, Daley GQ, Paskind M, Witte ON: Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. Proc Natl Acad Sci USA 83.9768, 1986
30. Hartung J, Elpelt B, Klösener KH: Statistik-Lehr-und Handbuch der angewandten Statistik. Munich, Germany, Oldenbourg, 1995
31. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
32. Henze G, Fengler R, Hartmann R: Chemotherapy for relapsed childhood acute lymphoblastic leukemia: Results of the BFM Study Group. Haematol Blood Transfus 36:374, 1994
33. Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG, Arlinghaus R, Pawson T: Bcr-Abl 2 oncoproteins bind directly to activators of the Ras signaling pathway. EMBO J 13:764, 1994
34. Lugo GT, Perdergast AM, Muller AJ, Witte ON: Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 245:1079, 1990
35. Roberts WM, Rivera G, Raimondi SC, Santana VM, Sandlund JT, Crist WM, Pui CH: Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukemia. Lancet 343:331, 1994
36. Barrett AJ, Horowitz MM, Ash RC, Atkinson K, Gale RP, Goldman JM, Henslee-Downey PJ, Herzig RH, Speck B, Zwaan FE, Bortin MM: Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 79:3067, 1992
37. Skorski T, Nieborowska-Skorska M, Barletta C, Malaguarnera L, Szcyzlik C, Chen ST, Lange B, Calabretta B: Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide. J Clin Invest 92:194, 1993
38. 1-positive leukemia cells and BCR/ABL oncoprotein-associated transformed cells. Leuk Lymph 10:307, 1993
39. Cullis JO, Barrett AJ, Goldman JM, Lechler RI: Binding of BCR/ABL junctional peptides to major histocompatibility complex (MHC) class I molecules: Studies in antigen-processing defective cell lines. Leukemia 8:165, 1994